지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
암등록과 암관리사업의 최신 국제 경향 및 우리나라 암발생 통계
예방의학회지
2008 .01
Prediction of Cancer Incidence and Mortality in Korea, 2020
Cancer Research and Treatment
2020 .01
Education for Cancer Patient
대한임상종양학회 학술대회지
2015 .02
Education for Cancer Patients
대한임상종양학회 학술대회지
2015 .02
Prediction of Cancer Incidence and Mortality in Korea, 2019
Cancer Research and Treatment
2019 .01
Analysis of Death Causes of In-patients with Malignant Tumors in Sichuan Cancer Hospital of China from 2002 to 2012
Asian Pacific journal of cancer prevention : APJCP
2013 .01
Prediction of Cancer Incidence and Mortality in Korea, 2016
Cancer Research and Treatment
2016 .01
서울시 암 발생률의 10년간 추이: 1993-2002
예방의학회지
2008 .01
Surgical Outcome of Synchronous Second Primary Cancer in Patients with Gastric Cancer
Yonsei Medical Journal
2007 .01
북한 이탈 주민에서 발생한 암의 임상병리적 특징
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2014 .12
Prediction of Cancer Incidence and Mortality in Korea, 2017
Cancer Research and Treatment
2017 .01
Metachronous Double Primary Cancer after Diagnosis of Gastric Cancer
Cancer Research and Treatment
2012 .01
Cancer Metabolism: Strategic Diversion from Targeting Cancer Drivers to Targeting Cancer Suppliers
Biomolecules & Therapeutics(구 응용약물학회지)
2015 .01
Projection of Cancer Incident Cases for India - Till 2026
Asian Pacific journal of cancer prevention : APJCP
2013 .01
Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer
Cancer Research and Treatment
2016 .01
Mortality of Major Cancers in Guangxi, China: Sex, Age and Geographical Differences from 1971 and 2005
Asian Pacific journal of cancer prevention : APJCP
2014 .01
Quality of Life of Family Members Living with Cancer Patients
Asian Pacific journal of cancer prevention : APJCP
2015 .01
How Can We Treat Cancer Disease Not Cancer Cells?
Cancer Research and Treatment
2017 .01
암 환자의 발생 초기 의료비와 이에 영향을 미치는 요인
예방의학회지
2009 .01
0